Evidence map›Paper›PMID 30755469›Full record

ArticleThe Journal of cell biology2019

Quantitative phosphoproteomics reveals mitotic function of the ATR activator ETAA1.

Thomas E Bass, David Cortez

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in The Journal of cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. DNA damage and repair in cardiomyopathy: mechanisms and therapeutic opportunities.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Key molecular DNA damage responses of human cells to radiation.Frontiers in cell and developmental biology · 2024
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Thomas E BassDepartment of Biochemistry, Vanderbilt University School of Medicine, Vanderbilt University, Nashville, TN.ORCID 0000-0002-8618-5266
David CortezDepartment of Biochemistry, Vanderbilt University School of Medicine, Vanderbilt University, Nashville, TN david.cortez@vanderbilt.edu.ORCID 0000-0003-0154-140X
Vanderbilt University · US

Funding

Function of the ATR-ATRIP ComplexR01CA102729 · NCI · VANDERBILT UNIVERSITY · PI CORTEZ, DAVID K · 2003 to 2018
$4.2M
Mechanisms and Functions of ATR signalingR01CA239161 · NCI · VANDERBILT UNIVERSITY · PI David K Cortez · 2019 to 2026
$3.3M
NCI NIH HHS R01 CA102729NCI NIH HHS R01 CA239161
6 · The paper itself

Abstract

The ATR kinase controls cell cycle transitions and the DNA damage response. ATR activity is regulated through two ATR-activating proteins, ETAA1 and TOPBP1. To examine how each activator contributes to ATR signaling, we used quantitative mass spectrometry to identify changes in protein phosphorylation in ETAA1- or TOPBP1-deficient cells. We identified 724, 285, and 118 phosphosites to be regulated by TOPBP1, ETAA1, or both ATR activators, respectively. Gene ontology analysis of TOPBP1- and ETAA1-dependent phosphoproteins revealed TOPBP1 to be a primary ATR activator for replication stress, while ETAA1 regulates mitotic ATR signaling. Inactivation of ATR or ETAA1, but not TOPBP1, results in decreased Aurora B kinase activity during mitosis. Additionally, ATR activation by ETAA1 is required for proper chromosome alignment during metaphase and for a fully functional spindle assembly checkpoint response. Thus, we conclude that ETAA1 and TOPBP1 regulate distinct aspects of ATR signaling with ETAA1 having a dominant function in mitotic cells.

Indexed as

Chromosome SegregationMitosisAntigens, SurfaceAntineoplastic Agents, PhytogenicAtaxia Telangiectasia Mutated ProteinsAurora Kinase BCarrier ProteinsDNA-Binding ProteinsDNA DamageEnzyme ActivationGene Expression Regulation, NeoplasticGenomic InstabilityHCT116 CellsHEK293 CellsHumansM Phase Cell Cycle CheckpointsAntigens, SurfaceAntineoplastic Agents, PhytogenicAtaxia Telangiectasia Mutated ProteinsATR protein, humanAURKB protein, humanAurora Kinase BCarrier ProteinsDNA-Binding ProteinsETAA1 protein, humanNuclear ProteinsPaclitaxelTOPBP1 protein, human

Identifiers

PMID30755469
PMCPMC6446857
OpenAlexW2912672694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.